Heading out to ASV 2025?
 Book time with our team in Montréal to discuss virus production, custom research tools, and more.

Advanced Virology Inc. Product Pipeline

Advanced Virology Inc. Product Pipeline

We are pleased to announce our upcoming virus product pipeline.

  • Products will be available to order as inventory is created.
  • Inactivated virus stocks, viral genetic material and purified/concentrated virus stocks for each listed virus strain will be added to our catalog at a later date. In the meantime, we are happy to create these products for customers on-demand on an ad hoc basis.
  • For on-demand orders, pre-orders, large volume orders or rush orders for any listed products, please contact us at info@advancedvirology.com.

Noroviruses:

  • Human norovirus Genogroup GI genotypes - 2, 3, 4, 6, 7, 8
  • Human norovirus Genogroup GII genotypes - 2, 3, 4, 6, 7, 8, 12, 16, 17, 20
  • Both virus stocks and quantified viral genomic material will be available.

Influenza viruses:

  • Five Influenza virus strains recommended by the FDA for inclusion in the 2025-2026 seasonal vaccine.
  • Strains recommended for the 2025-2026 seasonal Influenza vaccine will be added after selection by the FDA.
  • Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).

Strains:

  • A/Victoria/4897/2022 (H1N1)pdm09-like virus
  • A/Croatia/10136RV/2023 (H3N2)-like virus
  • A/Wisconsin/67/2022 (H1N1)pdm09-like virus
  • A/District of Columbia/27/2023 (H3N2)-like virus
  • B/Austria/1359417/2021 (B/Victoria lineage)-like virus

Human Parainfluenza viruses:

  • Parainfluenza virus Type 1
  • Parainfluenza virus Type 2
  • Parainfluenza virus Type 3
  • Parainfluenza virus Type 4
  • Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).

    Human Metapneumoviruses:

    • HMPV Type A1
    • HMPV Type A2a
    • HMPV Type A2b
    • HMPV Type B1
    • HMPV Type B2
    • Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).

    Respiratory Syncytial virus:

    • Challenge strain vaccine and antiviral testing - Memphis-37
    • Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).

        Coronaviruses:

        • Human coronavirus strain OC43
        • Human coronavirus strain 229E
        • Human coronavirus strain NL63
        • Human coronavirus strain HKU1
        • Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).

        Flaviviruses:

        • Yellow Fever vaccine strain 17-D
        • West Nile virus strain NY-99
        • Zika virus strain MR766
        • Zika virus strain PRVABC59
        • Dengue virus Type 1
        • Dengue virus Type 2
        • Dengue virus Type 3
        • Dengue virus Type 4
        • Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase and miRFP670nano3).

            Alphaviruses:

            • Sindbis virus (SINV) strain TR339.
            • Chikungunya virus (CHIKV) vaccine strain 181/25
            • Reporter protein expressing variants (EGFP, Nano-Luciferase, mCherry and miRFP670nano3).
            • Reporter proteins inserted after the capsid (TaV) or after nsP3 nonstructural protein.

            Chimeric alphaviruses: 

            • Allow the study of BSL-3 and Select Agent alphaviruses in BSL-2, non Select Agent approved laboratories.
            • Suitable for use in vaccine studies, diagnostic test development, antibody development and receptor studies.
            • Non-structural proteins - from Sindbis virus (SINV) strain TR339
            • Structural proteins - VEEV (Trinidad Donkey or ZPC738 strains), EEEV (FL93 or INH9813 K3E strains), CHIKV (La Reunion strain) or WEEV (McMillan strain).
            • Wild-type and reporter protein expressing variants (EGFP, Nano-Luciferase, mCherry).